Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05095818 · ClinicalTrials.gov registry record · NA

Impact of Nursing Involvement on Implementation of HIV Prevention Services

A NA study of Pre-Exposure Prophylaxis (PrEP), sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
440
Enrollment target
1
Study location

NCT05095818 is a NA study of Pre-Exposure Prophylaxis (PrEP) that has completed, run by Johns Hopkins University. The registered enrollment target is 440 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05095818, a NA study of Pre-Exposure Prophylaxis (PrEP), has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
440 participants
Enrollment target
1
Study location

Study Summary

Women comprise 20% of new Human Immunodeficiency Virus (HIV) diagnoses in the United States (U.S.) with 86% attributed to heterosexual contact. HIV pre-exposure prophylaxis (PrEP) uptake among cisgender women (women who are assigned female at birth and identify as women) is low. A randomized controlled trial (RCT) will assess the feasibility and effectiveness of a registered nurse (RN)-led PrEP project in Obstetrics and Gynecology (OB/GYN) clinics. The PrEP-RN will counsel patients about their risks for HIV acquisition via telemedicine. Under protocol guidance, the PrEP-RN will order laboratory tests and initiate PrEP for at-risk women. A total of 440 at-risk cisgender women will be randomized 1:1 to the standard of care with electronic medical record (EMR) enhancements (e-SOC) or e-SOC with the PrEP-RN.

Interventions

  • OTHER PrEP-RN

Study Locations (1)

Maryland

  • Johns Hopkins Outpatient Center - Baltimore

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2021-04-01
Est. Completion 2022-03-17
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05095818

The ClinicalTrials.gov registry entry for NCT05095818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pre-Exposure Prophylaxis (PrEP) appearing as the primary indexed condition, and to 1 intervention - of which PrEP-RN is the first listed.

NCT05095818 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05095818 about?

NCT05095818 is a clinical study titled "Impact of Nursing Involvement on Implementation of HIV Prevention Services". Women comprise 20% of new Human Immunodeficiency Virus (HIV) diagnoses in the United States (U.S.) with 86% attributed to heterosexual contact. HIV pre-exposure prophylaxis (PrEP) uptake among cisgender women (women who are assigned female at birth and identify as women) is low. A randomized contro...

What is the current status of trial NCT05095818?

This trial is currently completed. It is a NA study. The enrollment target is 440 participants. The study started on 2021-04-01. Estimated completion is 2022-03-17.

What conditions does trial NCT05095818 study?

This clinical trial studies the following conditions: Pre-Exposure Prophylaxis (PrEP).

What interventions are being tested in trial NCT05095818?

The interventions under investigation include: PrEP-RN (OTHER).

Who is sponsoring clinical trial NCT05095818?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05095818 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pre-Exposure Prophylaxis (PrEP)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.